Concepedia

Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded studies

Helen Marshall, Timo Vesikari, Peter Richmond, Jacek Wysocki, Leszek Szenborn, Johannes Beeslaar, Jason D. Maguire, Paul Balmer, Robert O’Neill, Annaliesa S. Anderson,

The Lancet Infectious Diseases · 2022 · 10 citations · 15 references

DOI

Concepts

References

15

Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

PEDIATRICS · 2013 · 1.8K citations · Full text

, , +12

Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group

S. Maslanka, L L Gheesling, Daniel Libutti et al. · Clinical and Diagnostic Laboratory Immunology · 1997 · 421 citations

, , +15

Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020

Sarah Mbaeyi, Catherine H. Bozio, Jonathan Duffy et al. · MMWR Recommendations and Reports · 2020 · 293 citations · Full text

, , +17

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England

Shamez Ladhani, Nick Andrews, Sydel R. Parikh et al. · New England Journal of Medicine · 2020 · 208 citations · Full text

, , +16

Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study

Russell Viner, Robert Booy, Helen Johnson et al. · The Lancet Neurology · 2012 · 198 citations

, , +11